• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Apogenix - Articles and news items


Encouraging top-line results for APG101 in myelodysplastic syndromes

Industry news / 15 June 2016 / Victoria White, Digital Content Producer

A Phase I trial showed that APG101 was well tolerated. In addition, the study showed that APG101 efficiently stimulates erythropoiesis in these patients…


Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +